Lundbeck loses €150m pay-for-delay appeal

30-03-2021

Alex Baldwin

Lundbeck loses €150m pay-for-delay appeal

Pavel Kapysh / Shutterstock.com

Lundbeck has lost an appeal to the Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics.


Lundbeck, CJEU, Xellia Pharmaceuticals, Alpharma

LSIPR